Dyslipidemia
Featured Article
“Our study demonstrates an opportunity in which a community health-system pharmacy department can use pharmacists and advanced practice nurses to provide services to employees and their spouses who have hypertension or dyslipidemia,” researchers wrote.
Regeneron and Sanofi announced plans to offer the PCSK9 inhibitor, Praluent (alirocumab), at a significantly reduced price starting early March 2019 in an effort to make the drug more available to…
In the second installment of this series, Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, discusses lifestyle risk, long-…